Literature DB >> 26662466

Changes in composition and sulfation patterns of glycoaminoglycans in renal cell carcinoma.

Ebru Ucakturk1, Orkun Akman2, Xiaojun Sun3,4,5,6, Dilek Ertoy Baydar2, Anil Dolgun7, Fuming Zhang3,4,5,6, Robert J Linhardt8,9,10,11.   

Abstract

Glycosaminoglycans (GAGs) are heterogeneous, linear, highly charged, anionic polysaccharides consisting of repeating disaccharides units. GAGs have some biological significance in cancer progression (invasion and metastasis) and cell signaling. In different cancer types, GAGs undergo specific structural changes. In the present study, in depth investigation of changes in sulfation pattern and composition of GAGs, heparan sulfate (HS)/heparin (HP), chondroitin sulfate (CS)/dermatan sulfate and hyaluronan (HA) in normal renal tissue (NRT) and renal cell carcinoma tissue (RCCT) were evaluated. The statistical evaluation showed that alteration of the HS (HSNRT = 415.1 ± 115.3; HSRCCT = 277.5 ± 134.3), and CS (CSNRT = 35.3 ± 12.3; CSRCCT = 166.7 ± 108.8) amounts (in ng/mg dry tissue) were statistically significant (p < 0.05). Sulfation pattern in NRT and RCCT was evaluated to reveal disaccharide profiles. Statistical analyses showed that RCCT samples contain significantly increased amounts (in units of ng/mg dry tissue) of 4SCS (NRT = 25.7 ± 9.4; RCCT = 117.1 ± 73.9), SECS (NRT = 0.7 ± 0.3; RCCT = 4.7 ± 4.5), 6SCS (NRT = 6.1 ± 2.7; RCCT = 39.4 ± 34.7) and significantly decreased amounts (in units of ng/mg dry tissue) of NS6SHS (RCCT = 28.6 ± 6.5, RCCT = 10.2 ± 8.0), NS2SHS (RCCT = 44.2 ± 13.8; RCCT = 27.2 ± 15.0), NSHS (NRT = 68.4 ± 15.8; RCCT = 50.4 ± 21.2), 2S6SHS (NRT = 1.0 ± 0.4; RCCT = 0.4 ± 0.3), and 6SHS (NRT = 60.6 ± 17.5; RCCT = 24.9 ± 12.3). If these changes in GAGs are proven to be specific and sensitive, they may serve as potential biomarkers in RCC. Our findings are likely to help us to show the direction for further investigations to be able to bring different diagnostic and prognostic approaches in renal tumors.

Entities:  

Keywords:  Biomarker; Glycosaminoglycans; Renal cell carcinoma; Sulfation pattern

Mesh:

Substances:

Year:  2015        PMID: 26662466     DOI: 10.1007/s10719-015-9643-1

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  60 in total

1.  A structural analysis of glycosaminoglycans from lethal and nonlethal breast cancer tissues: toward a novel class of theragnostics for personalized medicine in oncology?

Authors:  Amanda Weyers; Bo Yang; Dae Sung Yoon; Jong-Hwan Park; Fuming Zhang; Kyung Bok Lee; Robert J Linhardt
Journal:  OMICS       Date:  2012-03

Review 2.  Renal-cell carcinoma.

Authors:  Herbert T Cohen; Francis J McGovern
Journal:  N Engl J Med       Date:  2005-12-08       Impact factor: 91.245

Review 3.  International variations and trends in renal cell carcinoma incidence and mortality.

Authors:  Ariana Znaor; Joannie Lortet-Tieulent; Mathieu Laversanne; Ahmedin Jemal; Freddie Bray
Journal:  Eur Urol       Date:  2014-10-16       Impact factor: 20.096

4.  Disaccharide analysis of glycosaminoglycan mixtures by ultra-high-performance liquid chromatography-mass spectrometry.

Authors:  Bo Yang; Yuqing Chang; Amanda M Weyers; Eric Sterner; Robert J Linhardt
Journal:  J Chromatogr A       Date:  2011-12-26       Impact factor: 4.759

5.  Role of glycosaminoglycans in infectious disease.

Authors:  Akiko Jinno; Pyong Woo Park
Journal:  Methods Mol Biol       Date:  2015

6.  Altered content composition and structure of glycosaminoglycans and proteoglycans in gastric carcinoma.

Authors:  Achilleas D Theocharis; Demitrios H Vynios; Nikoletta Papageorgakopoulou; Spyros S Skandalis; Dimitrios A Theocharis
Journal:  Int J Biochem Cell Biol       Date:  2003-03       Impact factor: 5.085

7.  Role of glycosaminoglycans in cellular communication.

Authors:  Robert J Linhardt; Toshihiko Toida
Journal:  Acc Chem Res       Date:  2004-07       Impact factor: 22.384

Review 8.  The biological role of chondroitin sulfate in cancer and chondroitin-based anticancer agents.

Authors:  Athanasia P Asimakopoulou; Achilleas D Theocharis; George N Tzanakakis; Nikos K Karamanos
Journal:  In Vivo       Date:  2008 May-Jun       Impact factor: 2.155

9.  Structural analysis of bikunin glycosaminoglycan.

Authors:  Lianli Chi; Jeremy J Wolff; Tatiana N Laremore; Odile F Restaino; Jin Xie; Chiara Schiraldi; Toshihiko Toida; I Jonathan Amster; Robert J Linhardt
Journal:  J Am Chem Soc       Date:  2008-02-05       Impact factor: 15.419

Review 10.  Interactions between heparan sulfate and proteins: the concept of specificity.

Authors:  Johan Kreuger; Dorothe Spillmann; Jin-ping Li; Ulf Lindahl
Journal:  J Cell Biol       Date:  2006-07-31       Impact factor: 10.539

View more
  10 in total

1.  Glycosaminoglycans and glycolipids as potential biomarkers in lung cancer.

Authors:  Guoyun Li; Lingyun Li; Eun Ji Joo; Ji Woong Son; Young Jin Kim; Jae Ku Kang; Kyung Bok Lee; Fuming Zhang; Robert J Linhardt
Journal:  Glycoconj J       Date:  2017-08-18       Impact factor: 2.916

2.  Biomolecular analysis of matrix proteoglycans as biomarkers in non small cell lung cancer.

Authors:  Maristela P Rangel; Vanessa K de Sá; Tabatha Prieto; João Roberto M Martins; Eloísa R Olivieri; Dirce Carraro; Teresa Takagaki; Vera Luiza Capelozzi
Journal:  Glycoconj J       Date:  2018-03-03       Impact factor: 2.916

3.  Clinicopathological significance of ganglioside DSGb5 expression in renal cell carcinoma.

Authors:  Jun Itoh; Akihiro Ito; Shuichi Shimada; Yoshihide Kawasaki; Narihiko Kakoi; Hideo Saito; Koji Mitsuzuka; Mika Watanabe; Makoto Satoh; Seiichi Saito; Yoichi Arai
Journal:  Glycoconj J       Date:  2017-02-15       Impact factor: 2.916

4.  Integrated Omics Approaches Revealed the Osmotic Stress-Responsive Genes and Microbiota in Gill of Marine Medaka.

Authors:  Keng Po Lai; Peng Zhu; Delbert Almerick T Boncan; Lu Yang; Cherry Chi Tim Leung; Jeff Cheuk Hin Ho; Xiao Lin; Ting Fung Chan; Richard Yuen Chong Kong; William Ka Fai Tse
Journal:  mSystems       Date:  2022-03-14       Impact factor: 7.324

5.  Chondroitin sulfate synthase 1 enhances proliferation of glioblastoma by modulating PDGFRA stability.

Authors:  Wen-Chieh Liao; Chih-Kai Liao; To-Jung Tseng; Ying-Jui Ho; Ying-Ru Chen; Kuan-Hung Lin; Te-Jen Lai; Chyn-Tair Lan; Kuo-Chen Wei; Chiung-Hui Liu
Journal:  Oncogenesis       Date:  2020-02-04       Impact factor: 7.485

Review 6.  The dual role of the glycosaminoglycan chondroitin-6-sulfate in the development, progression and metastasis of cancer.

Authors:  Adam Pudełko; Grzegorz Wisowski; Krystyna Olczyk; Ewa Maria Koźma
Journal:  FEBS J       Date:  2019-02-05       Impact factor: 5.542

7.  A novel long non-coding RNA-based prognostic signature for renal cell carcinoma patients with stage IV and histological grade G4.

Authors:  Ning Li; Haiying Zhang; Keyao Hu; Jianfeng Chu
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

8.  Prognostic Value of Plasma and Urine Glycosaminoglycan Scores in Clear Cell Renal Cell Carcinoma.

Authors:  Francesco Gatto; Marco Maruzzo; Cristina Magro; Umberto Basso; Jens Nielsen
Journal:  Front Oncol       Date:  2016-11-24       Impact factor: 6.244

Review 9.  Glycosaminoglycan-Inspired Biomaterials for the Development of Bioactive Hydrogel Networks.

Authors:  Mariana I Neves; Marco Araújo; Lorenzo Moroni; Ricardo M P da Silva; Cristina C Barrias
Journal:  Molecules       Date:  2020-02-21       Impact factor: 4.411

10.  Chondroitin Sulfate Disaccharides, a Serum Marker for Primary Serous Epithelial Ovarian Cancer.

Authors:  Karina Biskup; Caroline Stellmach; Elena Ioana Braicu; Jalid Sehouli; Véronique Blanchard
Journal:  Diagnostics (Basel)       Date:  2021-06-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.